ChemicalBook > CAS DataBase List > Plozalizumab
Plozalizumab
- Product Name
- Plozalizumab
- CAS No.
- 1610761-46-0
- Chemical Name
- Plozalizumab
- Synonyms
- MLN-1202;Plozalizumab;Plozalizumab (anti-CCR2);Research Grade Plozalizumab;Research Grade Plozalizumab(DHE33201)
- CBNumber
- CB68080950
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Plozalizumab Property
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Plozalizumab Chemical Properties,Usage,Production
Uses
Plozalizumab (MLN-1202) is a specific humanized anti-CCR2 antibody. Plozalizumab can be used for malignant melanoma research[1].
IC 50
CCR2
References
[1] Jahchan NS, et al. Tuning the Tumor Myeloid Microenvironment to Fight Cancer. Front Immunol. 2019 Jul 25;10:1611. DOI:10.3389/fimmu.2019.01611
Plozalizumab Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Plozalizumab Suppliers
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- 15817493340
- 981810490@qq.com
- Country
- China
- ProdList
- 1566
- Advantage
- 58
- Tel
- 027-65317797 15926423062
- Fax
- QQ:422450190
- 422450190@qq.com
- Country
- China
- ProdList
- 10308
- Advantage
- 58
- Tel
- 4008200310
- marketing@tsbiochem.com
- Country
- China
- ProdList
- 24961
- Advantage
- 58
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
- Country
- China
- ProdList
- 9868
- Advantage
- 58
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com
- Country
- China
- ProdList
- 6762
- Advantage
- 58
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com
- Country
- China
- ProdList
- 11973
- Advantage
- 58
- Tel
- 0731-13823398 15111215862
- 313359644@qq.com
- Country
- China
- ProdList
- 4161
- Advantage
- 58
- Tel
- 17316404525 17316404525
- 209533805@qq.com
- Country
- China
- ProdList
- 9765
- Advantage
- 58
1610761-46-0, PlozalizumabRelated Search:
Alirocumab
Narnatumab
Vibostolimab
Codrituzumab
Mapatumumab
Intetumumab
Cemiplimab
Alemtuzumab
nimotuzumab
Talizumab